Delivery Order SPE2DB20D1109-SPE2DB25FP39F
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $6,000 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract, awarded under firm fixed pricing with no set-aside designation, calls for the delivery of RINVOQ ER 15 mg tablets in a 30-count unit dosage. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $101,921.94 by the Defense Logistics Agency on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract, awarded under firm fixed price terms with no set-aside designation, covers the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This delivery order is a child contract under AmerisourceBergen's significant...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $14,917.09 for RINVOQ ER 30 MG Tablet (UU 30s) by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and is classified as a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 3, 2025, valued at $91,328.55 for RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract type. The award, issued by the Defense Logistics Agency (DLA), was competitively awarded with no set-aside designation and has an ultimate completion date of September 4, 2025. This delivery order serves as a child contract under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for RINVOQ ER 30 mg tablets (30-unit packages) valued at $10,378.45. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary vendor fulfilling this pharmaceutical requirement through its...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $6,223.32 for RINVOQ ER 30 mg tablets (30-count units) under a firm fixed price contract type. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,136.53 for RINVOQ ER 15 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,223.32 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of RINVOQ ER (upadacitinib) 30 mg tablets in a quantity of 30 units. This firm fixed price, competitively awarded delivery order is not set-aside and is scheduled for completion by August 20, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a $8,405.21 delivery order on July 14, 2025, for RINVOQ ER 15 mg tablets (30-count units) under a competitively awarded, non-set-aside contract vehicle. The contract was funded by the Defense Medical Supply Chain and is set to be completed by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order utilizes firm fixed-price pricing and represents a child contract under the company's...